TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia
Clinical trial NCT03752138 · WITHDRAWN
Trial details
- NCT number
- NCT03752138
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-31
- Primary completion
- 2020-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.